Related references
Note: Only part of the references are listed.Prostaglandin E2 receptor 4 mediates renal cell carcinoma intravasation and metastasis
Yushan Zhang et al.
CANCER LETTERS (2017)
Dual inhibition of COX-2/5-LOX blocks colon cancer proliferation, migration and invasion in vitro
Xiao-Hang Che et al.
ONCOLOGY REPORTS (2016)
Upregulation of the S1P3 receptor in metastatic breast cancer cells increases migration and invasion by induction of PGE2 and EP2/EP4 activation
Iuliia Filipenko et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2016)
Inhibition of the Biosynthesis of Prostaglandin E2 By Low-Dose Aspirin: Implications for Adenocarcinoma Metastasis
Olivier Boutaud et al.
CANCER PREVENTION RESEARCH (2016)
Modulation by Licofelone and Celecoxib of Experimentally Induced Cancer and Preneoplastic Lesions in Mice Exposed to Cigarette Smoke
Roumen Balansky et al.
CURRENT CANCER DRUG TARGETS (2015)
Abnormal Expression of Prostaglandins E2 and F2α Receptors and Transporters in Patients with Endometriosis
Halima Rakhila et al.
BIOMED RESEARCH INTERNATIONAL (2015)
Berberine Inhibits Invasion and Metastasis of Colorectal Cancer Cells via COX-2/PGE2 Mediated JAK2/STAT3 Signaling Pathway
Xuan Liu et al.
PLOS ONE (2015)
Lipopolysaccharide-promoted proliferation of Caco-2 cells is mediated by c-Src induction and ERK activation
Tsung-Yao Lin et al.
BIOMEDICINE-TAIWAN (2015)
Prostaglandin E2 receptor EP4 as the common target on cancer cells and macrophages to abolish angiogenesis, lymphangiogenesis, metastasis, and stem-like cell functions
Mousumi Majumder et al.
CANCER SCIENCE (2014)
Evolving Personalized Therapy for Castration-Resistant Prostate Cancer
Hsin-Ho Liu et al.
BIOMEDICINE-TAIWAN (2014)
The decrease of cell membrane fluidity by the non-steroidal anti-inflammatory drug Licofelone inhibits epidermal growth factor receptor signalling and triggers apoptosis in HCA-7 colon cancer cells
Simona Tavolari et al.
CANCER LETTERS (2012)
Lymph Node Harvested in Laparoscopic Versus Open Colorectal Cancer Approaches: A Meta-analysis
Zhenjie Wu et al.
SURGICAL LAPAROSCOPY ENDOSCOPY & PERCUTANEOUS TECHNIQUES (2012)
Chemoprevention of Colon and Small Intestinal Tumorigenesis in APCMin/+ Mice by Licofelone, a Novel Dual 5-LOX/COX Inhibitor: Potential Implications for Human Colon Cancer Prevention
Altaf Mohammed et al.
CANCER PREVENTION RESEARCH (2011)
Wnt/β-Catenin Signaling Enhances Cyclooxygenase-2 (COX2) Transcriptional Activity in Gastric Cancer Cells
Felipe Nunez et al.
PLOS ONE (2011)
Gliotransmission by Prostaglandin E2: A Prerequisite for GnRH Neuronal Function?
Jerome Clasadonte et al.
Frontiers in Endocrinology (2011)
JNK suppression is essential for 17β-Estradiol inhibits prostaglandin E2-Induced uPA and MMP-9 expressions and cell migration in human LoVo colon cancer cells
Hsi-Hsien Hsu et al.
JOURNAL OF BIOMEDICAL SCIENCE (2011)
EP4 upregulation of Ras signaling and feedback regulation of Ras in human colon tissues and cancer cells
Cheng-Hsun Wu et al.
ARCHIVES OF TOXICOLOGY (2010)
Prostaglandin E2 Promotes Lung Cancer Cell Migration via EP4-βArrestin1-c-Src Signalsome
Jae Il Kim et al.
MOLECULAR CANCER RESEARCH (2010)
The role of COX-2 in intestinal inflammation and colorectal cancer
D. Wang et al.
ONCOGENE (2010)
Altered Expression of 15-Hydroxyprostaglandin Dehydrogenase in Tumor-Infiltrated CD11b Myeloid Cells: A Mechanism for Immune Evasion in Cancer
Evgeniy Eruslanov et al.
JOURNAL OF IMMUNOLOGY (2009)
Selective Inhibition of Prostaglandin E2 Receptors EP2 and EP4 Induces Apoptosis of Human Endometriotic Cells through Suppression of ERK1/2, AKT, NFκB, and β-Catenin Pathways and Activation of Intrinsic Apoptotic Mechanisms
Sakhila K. Banu et al.
MOLECULAR ENDOCRINOLOGY (2009)
Therapeutic targets in prostaglandin E2 signaling for neurologic disease
P. J. Cimino et al.
CURRENT MEDICINAL CHEMISTRY (2008)
Prostaglandin E2 - Making more of your marrow
Allegra M. Lord et al.
CELL CYCLE (2007)
PGE2 inhibits apoptosis in human adenocarcinoma Caco-2 cell line through Ras-PI3K association and cAMP-dependent kinase A activation
Vincenza Leone et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2007)
Prostaglandin E receptors
Yukihiko Sugimoto et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
EP4 mediates PGE2 dependent cell survival through the PI3 kinase/AKT pathway
Robert J. George et al.
PROSTAGLANDINS & OTHER LIPID MEDIATORS (2007)
Pathogenesis of colorectal carcinoma and therapeutic implications: the roles of the ubiquitin-proteasome system and Cox-2
Ioannis A. Voutsadakis
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2007)
Prostaglandin E receptor EP4 antagonism inhibits breast cancer metastasis
XR Ma et al.
CANCER RESEARCH (2006)
Coupling of COX-1 to mPGES1 for prostaglandin E2 biosynthesis in the murine mammary gland
S Chandrasekharan et al.
JOURNAL OF LIPID RESEARCH (2005)
Dual inhibition of 5-LOX and COX-2 suppresses colon cancer formation promoted by cigarette smoke
YN Ye et al.
CARCINOGENESIS (2005)
The role of gelatinases in colorectal cancer progression and metastasis
ORF Mook et al.
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2004)
Colon carcinoma cell growth is associated with prostaglandin E2/EP4 receptor-evoked ERK activation
A Pozzi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Gabexate mesilate inhibits colon cancer growth, invasion, and metastasis by reducing matrix metalloproteinases and angiogenesis
WH Yoon et al.
CLINICAL CANCER RESEARCH (2004)
Cancer therapy - Matrix metalloproteinase inhibitors and cancer: Trials and tribulations
LM Coussens et al.
SCIENCE (2002)
Control of β-catenin phosphorylation/degradation by a dual-kinase mechanism
CM Liu et al.
CELL (2002)
Mechanisms of prostaglandin E2-induced interleukin-6 release in astrocytes:: possible involvement of EP4-like receptors, p38 mitogen-activated protein kinase and protein kinase C
BL Fiebich et al.
JOURNAL OF NEUROCHEMISTRY (2001)
Specific inhibition of cyclooxygenase-2 results in inhibition of proliferation of oral cancer cell lines via suppression of prostaglandin E-2 production
H Sumitani et al.
JOURNAL OF ORAL PATHOLOGY & MEDICINE (2001)
Share Paper
